Lantern Pharma (Nasdaq: LTRN) Establishes Open-Medicine AI as a Separate Company to Commercialize and Expand Its Multi-Agent AI Co-Scientist Platform for the Transformation of Medicine – Business Wire

Lantern Pharma has established Open-Medicine AI as a separate company to commercialize and expand its multi-agent AI co-scientist platform for pharmaceutical development. The new entity will focus on scaling the AI platform’s capabilities to transform drug discovery and development processes. This separation allows Lantern Pharma to pursue dedicated commercialization strategies for its AI technology while maintaining its core pharmaceutical operations.

Read Full Article →